Everyday Health on MSN
How to treat psoriatic arthritis and psoriasis at the same time
Learn how to manage psoriatic arthritis and psoriasis simultaneously with the right medication and treatment plan. Discover ...
Morning Overview on MSN
Why psoriasis can flare in the same spots, according to skin cells?
Psoriasis plaques have a stubborn habit of returning to the exact same patches of skin, even after months or years of ...
Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) ...
In a new study in mice published on Thursday in Science, researchers showed how skin cells inherit patterns of gene ...
The clearance is the first for an oral peptide that blocks IL-23, the target of popular medicines like Skyrizi and Tremfya. J ...
The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...
Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could ...
Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to ...
The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced.
The breadth of data reinforces the company's expertise across dermatology and immunology, and reflects the ongoing commitment to safe, effective medications ...
"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results